You are here

  • Home
  • Archive
  • Volume 4, Issue 1
  • PERS&O (PERsistent Sitagliptin treatment & Outcomes): observational retrospective study on cardiovascular risk evolution in patients with type 2 diabetes on persistent sitagliptin treatment

Article metrics

Article menu

Download PDFPDF

XML
Cardiovascular and metabolic risk
PERS&O (PERsistent Sitagliptin treatment & Outcomes): observational retrospective study on cardiovascular risk evolution in patients with type 2 diabetes on persistent sitagliptin treatment

 

Online download statistics by month:

Online download statistics by month: July 2016 to March 2024

AbstractFullPdf
Jul 2016286215127
Aug 201626998104
Sep 20162228683
Oct 201625111353
Nov 201625012551
Dec 20161508937
Jan 2017268639
Feb 201703515
Mar 201725611
Apr 2017010010
May 201708017
Jun 2017236512
Jul 2017555821
Aug 2017464610
Sep 201760589
Oct 2017848413
Nov 2017616114
Dec 201747471
Jan 201847475
Feb 2018857714
Mar 201849506
Apr 201857578
May 201851567
Jun 201848495
Jul 201860606
Aug 201838385
Sep 2018757512
Oct 201811911915
Nov 201811411410
Dec 20181751755
Jan 20191401402
Feb 201914714710
Mar 2019747311
Apr 2019343314
May 2019302610
Jun 201955558
Jul 2019494811
Aug 201928289
Sep 201913134
Oct 201928273
Nov 201920208
Dec 201925246
Jan 202020168
Feb 202026237
Mar 202014147
Apr 202021214
May 2020121212
Jun 202014148
Jul 202018187
Aug 202014132
Sep 202029265
Oct 202041393
Nov 202015116
Dec 202023206
Jan 202125259
Feb 202112105
Mar 202122221
Apr 202154536
May 202113121
Jun 202122165
Jul 20212161
Aug 202135346
Sep 2021868611
Oct 2021383023
Nov 2021242411
Dec 202128278
Jan 202232312
Feb 20221851847
Mar 202221214
Apr 202212117
May 202211115
Jun 202210104
Jul 202224215
Aug 202222204
Sep 202216159
Oct 2022161610
Nov 202211115
Dec 2022131410
Jan 202317163
Feb 202340384
Mar 202311125
Apr 2023896
May 2023979
Jul 2023362319
Aug 202310610
Sep 2023121212
Oct 2023765
Nov 202313135
Dec 202319172
Jan 202464629
Feb 202496956
Mar 2024211842
Total475643241192